Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis

Chemico-Biological Interactions(2020)10.1016/j.cbi.2020.108965Source: DataRank Database

S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis is a research paper published in Chemico-Biological Interactions (2020). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

29 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: closedTopics (21)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Jianwei Zheng,June X. Zou ORCID,Jianzhen Xu ORCID,Fanghai Han ORCID,Songtao Xiang ORCID

Live enrichment

PubMed:32001260

National Natural Science Foundation of China

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S0009279719316825?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0009279719316825?httpAccept=text/plain

MeSH Terms

Cell Line, TumorHumansReactive Oxygen SpeciesTamoxifenMethyltransferasesHistone-Lysine N-MethyltransferaseS-AdenosylhomocysteineRepressor ProteinsAdenosineAntigens, LyApoptosisCell SurvivalGene Expression RegulationOxidation-ReductionHomeostasisUrokinase-Type Plasminogen ActivatorProteolysis

Keywords

Breast cancerTamoxifen ResistanceDznepNsd2

S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis

FAIR Checklist

Authors (9)

Funding (1 grants)

Open Access

Topics